Biodegradable Ionizable Cationic Lipids for Lower-Toxicity LNP Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing ionizable cationic lipids for nucleic acid delivery present varying physicochemical and toxicity profiles, necessitating improved compounds for effective nucleic acid delivery and reduced toxicity.
Innovation Solution
Development of novel ionizable cationic lipid compounds, including biodegradable groups, for forming lipid nanoparticles (LNPs) that enhance polynucleotide delivery, reduce toxicity, and improve in vivo clearance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing ionizable cationic lipids are used for nucleic acid delivery, then delivery effectiveness is achieved, but toxicity increases
Solution Approach 1:
The patent modifies the chemical structure of ionizable cationic lipids by changing parameters such as the hydrocarbon chain length (m=2-9), the nature of linkers (L1, L2), and the head group composition to create a series of lipids with different pKa values and toxicity profiles while maintaining nucleic acid delivery capability
Solution Approach 2:
The patent creates composite lipid structures combining hydrophobic hydrocarbon regions with hydrophilic ionizable head groups, where the specific composition and arrangement of these components can be optimized to achieve both effective delivery and reduced toxicity
2Adaptability or versatility
If different ionizable cationic lipids are used, then various physicochemical profiles are achieved, but it becomes difficult to select the optimal compound
Solution Approach 1:
The patent segments the lipid molecule into distinct functional regions (hydrophobic tail with defined carbon chain length, linker region with specific oxygen-containing groups, and hydrophilic head group) that can be independently optimized to achieve desired physicochemical properties
Solution Approach 2:
The patent systematically varies key parameters including the integer values m (2-9), n (0-6), o (1-8), p (0-9), and q (0-8) to create a structured series of compounds with predictable variations in pKa, solubility, and toxicity, making selection more systematic
3Productivity
If non-biodegradable lipids are used, then delivery efficiency is maintained, but in vivo clearance is impaired
Solution Approach 1:
The patent incorporates biodegradable ester or carbonate linkers (L1 and L2) with specific structures into the lipid backbone, where the bond cleavage properties can be tuned to allow gradual degradation in vivo while maintaining structural integrity during delivery
Solution Approach 2:
The patent creates composite structures where biodegradable linker segments are integrated into the otherwise stable lipid framework, allowing the molecule to remain intact during delivery but degrade into smaller, more readily cleared fragments after delivering the nucleic acid payload
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel lipid compounds improve complexation with polynucleotides, enhance encapsulation efficiency, and reduce toxicity, facilitating effective delivery and biodegradability, as demonstrated by comparable immune responses to existing vaccines.
Implementation Method 1
Ionizable cationic lipids are amphiphilic molecules having a lipophilic region containing one or more hydrocarbon groups and a hydrophilic region containing at least one positively charged or ionizable polar head group. Such cationic lipids are ionized at an appropriate pH and can then form a positively charged complex with nucleic acids
Data Source
AI summary
Novel ionizable lipid compounds of Formula I or Formula II are provided. The use of the compounds in forming lipid nanoparticles is described. The lipid nanoparticles may encapsulate a therapeutic, such as a nucleic acid, and these may be used in the delivery of the therapeutic and in methods of treating certain conditions or for inducing an immune response.